Salutaris Medical Devices, Inc. announces first subject treated in a clinical trial investigating the SMD-DA ophthalmic device for the treatment of neovascular Age-related Macular Degeneration (nAMD)

Salutaris Medical Devices, Inc.  announced the first subject was treated in a multi-center clinical trial investigating the use of its ophthalmic brachytherapy device to treat neovascular Age-related Macular Degeneration (nAMD) on May 23, 2018.Dr. Gregg Kokame, Principal Investigator (PI) at the clinical site in Honolulu successfully performed the first procedure using the SMD-DA device on … Continue reading Salutaris Medical Devices, Inc. announces first subject treated in a clinical trial investigating the SMD-DA ophthalmic device for the treatment of neovascular Age-related Macular Degeneration (nAMD)